Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) - comparison between 2004-2006, 2007-2009, and 2010-2012.

Nobumichi TanakaYasushi NakaiMakito MiyakeSatoshi AnaiTakeshi InoueTomomi FujiiNoboru KonishiKiyohide Fujimoto

Published in: BMC cancer (2017)

High-risk patients significantly decreased in the latter period. The use of PADT also significantly decreased, while radiation therapy and active surveillance significantly increased over these periods.

Keyphrases

prostate cancer
radiation therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
machine learning
radical prostatectomy
peritoneal dialysis
deep learning
prognostic factors
mesenchymal stem cells
combination therapy
locally advanced
rectal cancer
cell therapy